Systematic Escalation of diuREtics With Natriuresis in Heart Failure Patients: SERENA Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 198 participants.

Also called NCT04907123

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 198 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04907123
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04907123. Randomized; single masking; primary purpose treatment. Start 2021-10 (anticipated); primary completion 2024-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Systematic Escalation of diuREtics With Natriuresis in Heart Failure Patients: SERENA Trial
Acronym
SERENA
Condition
Heart Failure
Intervention (Other)
Intensive sodiuria-guided diuretic treatment
Intervention (Other)
Standard diuretic treatment
Lead sponsor
University of Turin, Italy (class: other)

Record details

Record id
cardio:ct-nct04907123
Content hash
fd82b2f18019d2ebeaa839646a49cf6c06f50397b6a9fc95fd6b0b8652116204